You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 286 No. 17, November 7, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (73)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Ophthalmology
 •Dry Eye Syndromes
 •Menopause
 •Alert me on articles by topic

Hormone Replacement Therapy and Dry Eye Syndrome

Debra A. Schaumberg, ScD,MPH; Julie E. Buring, ScD; David A. Sullivan, PhD; M. Reza Dana, MD,MPH

JAMA. 2001;286:2114-2119.

Context  Postmenopausal hormone replacement therapy (HRT) use is common in the United States. Some research suggests that estrogen may have detrimental effects on the tear film and could influence the development of dry eye syndrome, but few data are available on this relationship.

Objective  To determine the relationship of HRT and dry eye syndrome.

Design, Setting, and Participants  The Women's Health Study, a large cohort study in which 25 665 postmenopausal women provided information about use of HRT at baseline (1992), 12, and 36 months and dry eye syndrome at 48 months.

Main Outcome Measures  (1) Clinically diagnosed dry eye syndrome, as reported by participants; (2) severe symptoms (both ocular dryness and irritation either constantly or often); and (3) either clinically diagnosed dry eye syndrome or severe symptoms, compared between women who used HRT vs those who did not.

Results  For the combined end point of either clinically diagnosed dry eye syndrome or severe symptoms, the multivariable-adjusted odds ratios were 1.69 (95% confidence interval [CI], 1.49-1.91) for estrogen use alone and 1.29 (95% CI, 1.13-1.48) for estrogen plus progesterone/progestin use compared with no HRT use. Each 3-year increase in the duration of HRT use was associated with a significant 15% (95% CI, 11%-19%) elevation in risk of clinically diagnosed dry eye syndrome or severe symptoms. Results were similar for the combined end point of clinically diagnosed dry eye syndrome and severe symptoms.

Conclusions  These data suggest that women who use HRT, particularly estrogen alone, are at increased risk of dry eye syndrome. Physicians caring for women who are taking or considering HRT should be apprised of this potential complication.


Author Affiliations: Departments of Medicine (Dr Schaumberg), Ambulatory Care and Prevention (Dr Buring), and Ophthalmology (Drs Sullivan and Dana), Division of Preventive Medicine, Brigham and Women's Hospital (Drs Schaumberg and Buring), and Schepens Eye Research Institute (Drs Schaumberg, Sullivan, and Dana), Harvard Medical School, and Department of Epidemiology, Harvard School of Public Health (Dr Buring), Boston, Mass.


RELATED LETTER

Dry Eye Syndrome in Postmenopausal Women
Chris M. Peterson, Jack L. Lesher, Jr, Loretta S. Davis, Debra A. Schaumberg, and M. Reza Dana
JAMA. 2002;287(5):585-586.
EXTRACT | FULL TEXT  

RELATED ARTICLE

November 7, 2001
JAMA. 2001;286(17):2171-2172.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Estrogen and Progesterone Control of Gene Expression in the Mouse Meibomian Gland
Suzuki et al.
IOVS 2008;49:1797-1808.
ABSTRACT | FULL TEXT  

Elevated prolactin redirects secretory vesicle traffic in rabbit lacrimal acinar cells
Wang et al.
Am. J. Physiol. Endocrinol. Metab. 2007;292:E1122-E1134.
ABSTRACT | FULL TEXT  

Identification and comparison of the polar phospholipids in normal and dry eye rabbit tears by maldi-tof mass spectrometry.
Ham et al.
IOVS 2006;47:3330-3338.
ABSTRACT | FULL TEXT  

Cytochrome P450 3A Expression and Activity in the Rabbit Lacrimal Gland: Glucocorticoid Modulation and the Impact on Androgen Metabolism
Attar et al.
IOVS 2005;46:4697-4706.
ABSTRACT | FULL TEXT  

Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women
Miljanovic et al.
Am. J. Clin. Nutr. 2005;82:887-893.
ABSTRACT | FULL TEXT  

Flushing and Papules in a Middle-Aged Woman
Nygaard
Obstet Gynecol 2005;105:1482-1483.
FULL TEXT  

Female Reproductive Factors and Eye Disease in a Rural South Indian Population: The Aravind Comprehensive Eye Survey
Nirmalan et al.
IOVS 2004;45:4273-4276.
ABSTRACT | FULL TEXT  

Dry Eye Signs and Symptoms in Women With Premature Ovarian Failure
Smith et al.
Arch Ophthalmol 2004;122:151-156.
ABSTRACT | FULL TEXT  

Hormonal Deficiencies and Dry Eye
Pflugfelder
Arch Ophthalmol 2004;122:273-274.
FULL TEXT  

Female reproductive factors and open angle glaucoma: the Blue Mountains Eye Study
Lee et al.
Br. J. Ophthalmol. 2003;87:1324-1328.
ABSTRACT | FULL TEXT  

Minerva
BMJ 2003;327:E94-94.
FULL TEXT  

Regulation of Estrogen Receptors and MMP-2 Expression by Estrogens in Human Retinal Pigment Epithelium
Marin-Castano et al.
IOVS 2003;44:50-59.
ABSTRACT | FULL TEXT  

Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia
Lee et al.
Br. J. Ophthalmol. 2002;86:1347-1351.
ABSTRACT | FULL TEXT  

Blepharospasm: Recent advances
Hallett
Neurology 2002;59:1306-1312.
ABSTRACT | FULL TEXT  

Identification of Estrogen and Progesterone Receptor mRNA Expression in the Conjunctiva of Premenopausal Women
Fuchsjager-Mayrl et al.
IOVS 2002;43:2841-2844.
ABSTRACT | FULL TEXT  

Dry Eye Syndrome in Postmenopausal Women
Peterson et al.
JAMA 2002;287:585-586.
FULL TEXT  

Does HT Increase Risk for Dry Eye Syndrome?
JWatch Women's Health 2001;2001:10-10.
FULL TEXT  

Does HRT Increase Risk for Dry Eye Syndrome?
JWatch General 2001;2001:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.